Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world
These data should be considered by guideline-issuing agencies and organizations to develop education campaigns encouraging more frequent use of tests beyond the standard lipid panel.
Authors
- Robert J. Sanchez
- Fátima Rodríguez (ORCID: https://orcid.org/0000-0002-5226-0723)
- Gregory P. Geba (ORCID: https://orcid.org/0000-0001-8936-748X)
- Dana J. Murdock
- Sergio Fazio (ORCID: https://orcid.org/0000-0002-2743-9836)
- Jing Gu (ORCID: https://orcid.org/0000-0001-5735-8482)
- Keran Moll
Institutions
- Regeneron (United States) (US)
- Stanford University (US)
Publication Details
- Journal
- American Journal of Preventive Cardiology
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1016/j.ajpc.2024.100721
- Citations
- 8
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 4.58
Funders
- Regeneron Pharmaceuticals